Pernix Therapeutics Holdings Inc


Pernix Therapeutics Holdings Inc (PTX) Announces 2Q:17 Financial Results and Provides Business Update

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced financial results for the three and six months ended June 30, 2017. Second Quarter 2017 Financial Highlights: Second …

Pernix Therapeutics Holdings Inc Joins Russell Microcap Index

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced today that it has been added to the Russell Microcap® index following the annual reconstitution, which took …

Pernix Therapeutics Holdings Inc (PTX) Shares Take a Hit on Default Warning

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares are tumbling 25% in after-hours trading after the drug maker said that a failure to raise capital and repay all …

Pernix Therapeutics Holdings Inc’s (PTX) 20mg Zohydro ER with BeadTek Delayed by Manufacturing Snag

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that, due to a manufacturing issue with its supplier, the Company expects that the 20mg strength of …

Pernix Therapeutics (PTX) Reports 4Q and Full Year 2016 Results

Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) announced financial results for the three and twelve months ended December 31, 2016.

Pernix Therapeutics Holdings Inc (PTX) Shares Jump on Back of Favorable Opinion in Zohydro ER Litigation

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) investors have a smile on their faces Thursday morning, after the pharmaceutical firm announced that it received a favorable …

Friday’s Market Insights: Cerulean Pharma Inc (CERU), Pernix Therapeutics Holdings Inc (PTX) and GoPro Inc (GPRO)

Cerulean Pharma Inc (NASDAQ:CERU) are catapulting 60% after the cancer drug-maker has decided to confront recent missteps with the consideration of M&A possibilities. …

Stock Update (NASDAQ:PTX): Here’s Why Pernix Therapeutics Holdings Inc Shares Are Falling 17%

Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) tumbled nearly 17% this morning after investors learned that a Pernix and GSK had been in arbitration …

Company Update (NASDAQ:PTX): Here’s Why Pernix Therapeutics Holdings Inc Shares Are Soaring 29% Today

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Ken Piña as Senior Vice President, General Counsel and Chief Compliance Officer.  Mr.

Company Update (NASDAQ:PTX): Pernix Therapeutics Holdings Inc Appoints New Member to Board of Directors

Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Gabriel Leung to its Board of Directors, effective immediately. The Board also determined that …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts